Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7575730 | 0.85 | TDP1 (0.41) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL2201472 | 0.81 | TDP1 (0.41) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL670416 | 0.81 | TDP1 (0.41) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL3836310 | 0.81 | TDP1 (0.41) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL3795378 | 0.80 | TP53 (0.32) | TDP1TSHRTP53 | |
| SCHEMBL7574669 | 0.78 | TDP1 (0.50) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL4858974 | 0.78 | TDP1 (0.39) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL4852532 | 0.76 | TDP1 (0.44) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL8650694 | 0.75 | TDP1 (0.46) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 | |
| SCHEMBL6154152 | 0.75 | TDP1 (0.46) | TDP1TSHRCYP3A4NPSR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020042055-A1 | Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions | MAXYGEN, INC. | 2002-04-11 | — | — | US | disclosed |
| WO-2001046476-A1 | ALTERATION OF HYDROLASE GENES AND SCREENING OF THE RESULTING LIBRARIES FOR THE ABILITY TO CATALYZE SPECIFIC REACTIONS | MAXYGEN, INC. (US) | 2001-06-28 | — | — | WO | disclosed |